Literature DB >> 4628112

Experimental visceral aspergillosis.

H Sidransky, S M Epstein, E Verney, C Horowitz.   

Abstract

Studies conducted to gain insight into the pathogenesis of experimental aspergillosis indicated that mice pretreated with cortisone acetate and then injected intraperitoneally with nongerminating spores of Aspergillus flavus developed a high incidence of lethal visceral hyphal aspergillosis. A similar, high incidence of fatal infections was observed in cortisone-treated animals in which the number of peritoneal macrophages had been increased by prior injection of thioglycollate. To determine whether germination of spores within the host was important to the subsequent development of disseminated hyphal aspergillosis, germinating spores of A flavus were injected intraperitoneally into normal animals. While a similar dose of nongerminating spores, administered intraperitoneally into normal mice, induced a low incidence of lethal injection, germinating spores induced a high incidence of fatal disease associated with widely disseminated visceral hyphal aspergillosis. Our studies indicate that phagocytic cells in the peritoneal cavity of normal mice are able to ingest nonperminating spores of A flavus and kill them, preventing germination. However, the phagocytic cells are unable to cope with early germinating spores, which then continue to proliferate, leading to extensive hyphal invasion of visceral organs and death.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4628112      PMCID: PMC2032775     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  EXPERIMENTAL PULMONARY ASPERGILLOSIS.

Authors:  H SIDRANSKY; E VERNEY; H BEEDE
Journal:  Arch Pathol       Date:  1965-03

2.  Effects of fat-soluble compounds on lysosomes in vitro.

Authors:  C DE DUVE; R WATTIAUX; M WIBO
Journal:  Biochem Pharmacol       Date:  1962-08       Impact factor: 5.858

3.  Phycomycosis. A clinicopathologic study of fifty-one cases.

Authors:  B R STRAATSMA; L E ZIMMERMAN; J D GASS
Journal:  Lab Invest       Date:  1962-11       Impact factor: 5.662

4.  The influence of cortisone on experimental fungus infections in mice.

Authors:  D B LOURIA; N FALLON; H G BROWNE
Journal:  J Clin Invest       Date:  1960-09       Impact factor: 14.808

5.  Experimental mucormycosis (Rhizopus infection) in mice; the failure of chronic alloxan diabetes to modify host susceptibility.

Authors:  R A SCHOFIELD; R D BAKER
Journal:  AMA Arch Pathol       Date:  1956-05

6.  A stain for fungi in tissue sections.

Authors:  M F GRIDLEY
Journal:  Am J Clin Pathol       Date:  1953-03       Impact factor: 2.493

7.  Systemic fungal infections complicating renal transplantation and immunosuppressive therapy. Clinical, microbiologic, neurologic and pathologic features.

Authors:  D Rifkind; T L Marchioro; S A Schneck; R B Hill
Journal:  Am J Med       Date:  1967-07       Impact factor: 4.965

8.  Lysosomal stability during phagocytosis of Aspergillus flavus spores by alveolar macrophages of cortisone-treated mice.

Authors:  L Merkow; M Pardo; S M Epstein; E Verney; H Sidransky
Journal:  Science       Date:  1968-04-05       Impact factor: 47.728

9.  Experimental study of the pathogenicity of aspergilli for mice.

Authors:  S Ford; L Friedman
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

10.  Studies on lysosomes. I. The effects of endotoxin, endotoxin tolerance, and cortisone on the release of acid hydrolases from a granular fraction of rabbit liver.

Authors:  G WEISSMANN; L THOMAS
Journal:  J Exp Med       Date:  1962-10-01       Impact factor: 14.307

View more
  8 in total

1.  Experimental aspergillosis in rats infected via intraperitoneal and subcutaneous routes.

Authors:  K J Turner; R Hackshaw; J Papadimitriou; J D Wetherall; J Perrott
Journal:  Immunology       Date:  1975-07       Impact factor: 7.397

2.  Chitin assay used to demonstrate renal localization and cortisone-enhanced growth of Aspergillus fumigatus mycelium in mice.

Authors:  P F Lehmann; L O White
Journal:  Infect Immun       Date:  1975-11       Impact factor: 3.441

3.  Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis.

Authors:  R D Diamond; R Krzesicki; B Epstein; W Jao
Journal:  Am J Pathol       Date:  1978-05       Impact factor: 4.307

4.  Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice.

Authors:  M H Kothary; T Chase; J D Macmillan
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

5.  Chromoblastomycosis. A morphological investigation of the host-parasite interaction.

Authors:  P Walter; Y Garin; D Richard-Lenoble
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

6.  The effect of elastase-specific monoclonal and polyclonal antibodies on the virulence of Aspergillus fumigatus in immunocompromised mice.

Authors:  M B Frosco; T Chase; J D Macmillan
Journal:  Mycopathologia       Date:  1994-02       Impact factor: 2.574

7.  Comparison of the growth of virulent and attenuated strains of Candida albicans in the kidneys of normal and cortison-treated mice by chitin assay.

Authors:  L O White; E Gibb; H C Newham; M D Richardson; R C Warren
Journal:  Mycopathologia       Date:  1979-07-16       Impact factor: 2.574

8.  Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes.

Authors:  A Schaffner; H Douglas; A Braude
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.